These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28132854)

  • 21. Oxidative Stress-Induced HMGB1 Release from Melanocytes: A Paracrine Mechanism Underlying the Cutaneous Inflammation in Vitiligo.
    Cui T; Zhang W; Li S; Chen X; Chang Y; Yi X; Kang P; Yang Y; Chen J; Liu L; Jian Z; Li K; Wang G; Gao T; Song P; Li C
    J Invest Dermatol; 2019 Oct; 139(10):2174-2184.e4. PubMed ID: 30998983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
    Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
    J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of the NKG2D in Vitiligo.
    Plaza-Rojas L; Guevara-Patiño JA
    Front Immunol; 2021; 12():624131. PubMed ID: 33717132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic alterations in chemokine gradients induce transendothelial shuttling of human T cells under physiologic shear conditions.
    Lee JY; Buzney CD; Poznansky MC; Sackstein R
    J Leukoc Biol; 2009 Dec; 86(6):1285-94. PubMed ID: 19797295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
    Xie H; Zhou F; Liu L; Zhu G; Li Q; Li C; Gao T
    J Dermatol Sci; 2016 Jan; 81(1):3-9. PubMed ID: 26387449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
    Palermo B; Campanelli R; Garbelli S; Mantovani S; Lantelme E; Brazzelli V; Ardigó M; Borroni G; Martinetti M; Badulli C; Necker A; Giachino C
    J Invest Dermatol; 2001 Aug; 117(2):326-32. PubMed ID: 11511311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of T cells in early evolving segmental vitiligo.
    Shin J; Kang HY; Kim KH; Park CJ; Oh SH; Lee SC; Lee S; Choi GS; Hann SK
    Clin Exp Dermatol; 2016 Aug; 41(6):671-4. PubMed ID: 27334675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occludin Promotes Adhesion of CD8
    Zou P; Xiao Y; Deng Q; Shi Y; You R; Pi Z; Liu J; Zhan Y; Zeng Q; Zeng Z; Xiao R
    Oxid Med Cell Longev; 2022; 2022():6732972. PubMed ID: 35222802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitiligo Pathogenesis and Emerging Treatments.
    Rashighi M; Harris JE
    Dermatol Clin; 2017 Apr; 35(2):257-265. PubMed ID: 28317534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling.
    Martins C; Migayron L; Drullion C; Jacquemin C; Lucchese F; Rambert J; Merhi R; Michon P; Taieb A; Rezvani HR; de Rinaldis E; Seneschal J; Boniface K
    J Invest Dermatol; 2022 Apr; 142(4):1194-1205.e7. PubMed ID: 34655610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.
    van Geel NA; Mollet IG; De Schepper S; Tjin EP; Vermaelen K; Clark RA; Kupper TS; Luiten RM; Lambert J
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):375-84. PubMed ID: 20370855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S100B: Correlation with Active Vitiligo Depigmentation.
    Birlea SA
    J Invest Dermatol; 2017 Jul; 137(7):1408-1410. PubMed ID: 28647026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
    Lang KS; Caroli CC; Muhm A; Wernet D; Moris A; Schittek B; Knauss-Scherwitz E; Stevanovic S; Rammensee HG; Garbe C
    J Invest Dermatol; 2001 Jun; 116(6):891-7. PubMed ID: 11407977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for an autoimmune pathogenesis of vitiligo.
    Ongenae K; Van Geel N; Naeyaert JM
    Pigment Cell Res; 2003 Apr; 16(2):90-100. PubMed ID: 12622785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.
    Jadeja SD; Mayatra JM; Vaishnav J; Shukla N; Begum R
    Front Immunol; 2020; 11():624566. PubMed ID: 33613564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunopathogenesis of vitiligo.
    Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A
    Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo.
    Das PK; van den Wijngaard RM; Wankowicz-Kalinska A; Le Poole IC
    Trends Immunol; 2001 Mar; 22(3):130-6. PubMed ID: 11286727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-32γ induces chemotaxis of activated T cells via dendritic cell-derived CCL5.
    Son MH; Jung MY; Choi S; Cho D; Kim TS
    Biochem Biophys Res Commun; 2014 Jul; 450(1):30-5. PubMed ID: 24882804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.